WEKO3
アイテム
The effect of memantine on sleep architecture and psychiatric symptoms in patients with Alzheimer's disease
https://kagawa-u.repo.nii.ac.jp/records/390
https://kagawa-u.repo.nii.ac.jp/records/390f13d3eca-2c26-4f40-a432-63fada1768ef
名前 / ファイル | ライセンス | アクション |
---|---|---|
内容の要旨 (88.7 kB)
|
|
|
審査の結果の要旨 (515.8 kB)
|
|
Item type | 学位論文 / Thesis or Dissertation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2019-07-18 | |||||
タイトル | ||||||
タイトル | The effect of memantine on sleep architecture and psychiatric symptoms in patients with Alzheimer's disease | |||||
言語 | en | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_db06 | |||||
資源タイプ | doctoral thesis | |||||
アクセス権 | ||||||
アクセス権 | open access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||
著者 |
石川, 一朗
× 石川, 一朗 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Objective: Behavioural and psychological symptoms of dementia (BPSD) are commonly present in patients with Alzheimer's disease (AD). Disturbed sleep quality is also observed in AD patients. However, the effects of memantine on sleep architecture have not been investigated. The purpose of this study was to investigate the effects of memantine on polysomnography (PSG) variables and BPSD. | |||||
言語 | en | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Methods: In total, 12 patients with AD (mean age: 79.0±4.1 years old) were enrolled in this study. The following tests were performed: the Neuropsychiatric Inventory for the assessment of BPSD, the Mini-Mental State Examination (MMSE) for cognitive function, and PSG for evaluation of sleep architecture. After baseline examinations, patients were treated with memantine according to a standard prescription protocol. After being treated with 20 mg/day of memantine for 4 weeks, examinations were carried out again. | |||||
言語 | en | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Results: All subjects completed the trial. The mean MMSE and NPI scores were 22.6±3.4 and 13.8±12.9, respectively. Treatment with memantine significantly decreased the NPI score (5.8±4.3, p<0.01). There were significant decreases in the scores of subscales for anxiety (p=0.04) and irritability/lability (p=0.04). PSG demonstrated a longer total sleep time (TST) (p<0.01), increases in sleep efficiency (p<0.01) and time spent in stage II (% TST, p=0.02), and decreases in nocturnal awakening (p<0.01), the periodic limb movement index (p<0.01), and time spent in stage I (% TST, p=0.02). | |||||
言語 | en | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Conclusion: Memantine was effective for reducing fragmented sleep and improving BPSD, and was well tolerated. | |||||
言語 | en | |||||
学位名 | ||||||
言語 | ja | |||||
学位名 | 博士(医学) | |||||
学位授与機関 | ||||||
学位授与機関識別子Scheme | kakenhi | |||||
学位授与機関識別子 | 16201 | |||||
言語 | ja | |||||
学位授与機関名 | 香川大学 | |||||
言語 | en | |||||
学位授与機関名 | Kagawa University | |||||
学位授与年月日 | ||||||
学位授与年月日 | 2016-03-24 | |||||
学位授与番号 | ||||||
学位授与番号 | 甲第636号 | |||||
権利 | ||||||
言語 | en | |||||
権利情報 | Copyright © Scandinavian College of Neuropsychopharmacology 2015 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 26572055 | |||||
関連サイト | ||||||
関連タイプ | isVersionOf | |||||
識別子タイプ | DOI | |||||
関連識別子 | https://doi.org/10.1017/neu.2015.61 | |||||
著者版フラグ | ||||||
出版タイプ | NA | |||||
出版タイプResource | http://purl.org/coar/version/c_be7fb7dd8ff6fe43 | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | Alzheimer’s disease | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | behavioural and psychological symptoms of dementia (BPSD) | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | N-methyl-D-aspartate | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | periodic limb movement | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | polysomnography | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
KEID | ||||||
値 | 28753 |